Mon, August 6, 2018
Fri, August 3, 2018
Thu, August 2, 2018

David Risinger Maintained (TEVA) at Hold with Increased Target to $20 on, Aug 3rd, 2018

  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. with-increased-target-to-20-on-aug-3rd-2018.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
David Risinger of Morgan Stanley, Maintained "Teva Pharmaceutical Industries Limited" (TEVA) at Hold with Increased Target from $19 to $20 on, Aug 3rd, 2018.

David has made no other calls on TEVA in the last 4 months.



There are 4 other peers that have a rating on TEVA. Out of the 4 peers that are also analyzing TEVA, 3 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Louise Chen of "Cantor Fitzgerald" Maintained at Hold with Increased Target to $25 on, Monday, July 16th, 2018
  • Jacob Hughes of "Wells Fargo" Upgraded from Sell to Hold on, Monday, June 18th, 2018
  • Douglas Tsao of "Barclays" Maintained at Hold with Increased Target to $20 on, Thursday, May 24th, 2018


This is the rating of the analyst that currently disagrees with David


  • Liav Abraham of "Citigroup" Maintained at Strong Buy with Increased Target to $25 on, Thursday, May 31st, 2018